Five Russian startups – the winners of the Startup Challenge accelerator organised jointly by the Skolkovo Foundation and multinational pharma giant AstraZeneca – are showcasing their inventions at the International Future Healthcare Forum in the...
Insilico Medicine , the parent company of Skolkovo resident biomed startup Insilico , has published a peer-review research paper calling for patients to regain control of their personal medical records, and even to profit from them. The Baltimore-based Insilico...
The Skolkovo Foundation has signed a strategic partnership agreement with the multinational pharmaceuticals giant AstraZeneca to carry out joint scientific research and educational activities in Russia. Irina Panarina, director of AstraZeneca Russia and...
3D Bioprinting Solutions , a resident company of the Skolkovo Foundation that made headlines last year when it printed the world’s first functional thyroid construct for a mouse, is to make a 3D bioprinter for printing tissue and organ constructs on board...
As the world discusses the ethics of growing human organs in pigs , scientists gathered at the Skolkovo Foundation last week to discuss an equally divisive topic: that of human genome modification. Scientists in the U.S. are currently making headlines...
The Skolkovo Foundation’s biomedicine cluster is to study the creation of a genetics centre that would guarantee Russia’s agricultural independence, after the foundation’s council approved the plan’s development. Biomedicine cluster...
As nations across the globe marked World Cancer Day on February 4, the Skolkovo Foundation announced the creation of a new Cancer Centre of Excellence. The new centre is set to coordinate the work of all the startup companies and partners currently working...
ГАВАНА. В кубинской столице открылся V Международный научно-технологический семинар NANO, в работе которого принимает участие делегация «Сколково». Газета Granma вынесла на первую полосу две новости дня. Помимо открытия научного форума, в котором...
На Петербургском международном экономическом форуме компания IBM, Фонд «Сколково» и Первый Онкологический Научно-Консультационный Центр (ПОНКЦ) подписали меморандум о взаимопонимании. Документ предусматривает формирование первого в своем роде стратегического...
Hundreds of Moscow students packed out a lecture theater this week to hear what most of them already believe: Pharma’s Cool. The lecture hall at Moscow’s Sechenov University of Medicine. Photo: sk.ru The three-week lecture series targeting...
NCL, a resident of Skolkovo’s biomed cluster, has unveiled a prototype laser lancet – a contactless device that punctures the skin to harvest capillary blood samples. The lancet is intended for use by professional medical personnel for the collection...
A Skolkovo resident company is about to unveil one of the world’s most advanced 3D bioprinters, thrusting Russia to the frontier of regenerative medicine. A bioprinter is a machine that fabricates human cells, a technology that could revolutionize...
В Москве в четверг открылся новый научно-исследовательский центр компании «БАЙНД (РУС)», резидента биомедицинского кластера Фонда «Сколково». В лабораториях на базе Технопарка «Слава» будут разрабатывать лекарства направленного...